Your session is about to expire
← Back to Search
Lung Cancer Screening Promotion for Lung Cancer
N/A
Waitlist Available
Led By Katharine Rendle, PhD,MSW,MPH
Research Sponsored by Abramson Cancer Center at Penn Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months of study enrollment
Awards & highlights
Summary
This trial assesses a new way to communicate lung cancer risk to people in polluted areas, to help reduce lung cancer burden and disparities.
Who is the study for?
This trial is for individuals aged 50-80 who have a significant history of smoking and have visited Penn Medicine in the last two years. They must live in specific zip codes, speak English, and be able to view videos and take surveys online. Those with previous lung cancer screenings or diagnoses are excluded.
What is being tested?
Project PLUS tests an enhanced risk communication approach to encourage lung cancer screening intentions among people from areas with high environmental pollution. It involves comparing reactions to an intervention video versus a control video after conducting qualitative interviews.
What are the potential side effects?
Since this study focuses on educational videos rather than medical treatments, there are no direct side effects related to medications or interventions typically associated with clinical trials.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 months of study enrollment
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months of study enrollment
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
The number of patients who intend or do obtain lung cancer screening within the next 3 months.
Secondary study objectives
Completion of lung cancer screening
Trial Design
2Treatment groups
Experimental Treatment
Group I: Intervention ArmExperimental Treatment1 Intervention
This arm includes patients who view the integrated health video that provides information about both smoking and environmental risk.
Group II: Control Video ArmExperimental Treatment1 Intervention
This arm includes patients who view the integrated health video that provides information ONLY about smoking risk.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Control video
2022
N/A
~1450
Intervention video
2018
N/A
~230
Find a Location
Who is running the clinical trial?
Abramson Cancer Center at Penn MedicineLead Sponsor
403 Previous Clinical Trials
155,961 Total Patients Enrolled
Katharine Rendle, PhD,MSW,MPHPrincipal InvestigatorUniversity of Pennsylvania
2 Previous Clinical Trials
2,080 Total Patients Enrolled
Andy Tan, PhD,MPH,MBAPrincipal InvestigatorUniversity of Pennsylvania
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have already taken part in interviews with patients as part of a trial.Participants must be between 50 and 80 years old.You have smoked at least 20 packs of cigarettes a year and have either quit smoking in the last 15 years or are still smoking.You have a record of getting screened for lung cancer or have had lung cancer before.You have smoked an average of one pack of cigarettes per day for 20 years, and have either quit within the last 15 years or are still smoking.Participants who have not had a lung cancer screening or have not been diagnosed with lung cancer.
Research Study Groups:
This trial has the following groups:- Group 1: Intervention Arm
- Group 2: Control Video Arm
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger